Skip to content
Head to head

Dolby Laboratories vs Cintas

Side-by-side on the measures that matter, with a plain-English read. Full detail: DLB · CTAS

Updated 8 minutes ago

1-year performance, rebased to 100

DLB -12.9%CTAS +20.5%
Cintas edges it on the scoreable measures. Cintas has the highest Quant Rating (66); Cintas has done best over the past year (+21%); Cintas earns the most per share.
DLBCTAS
Snapshot
SectorSpecialty Business ServicesSpecialty Business Services
Last price55.33220.01
Change today+1.02%+0.50%
1-year return-13.6%+21.0%
Market cap$5.13B$87.36B
52-week range47.98 – 69.11159.94 – 232.93
Valuation
P/E (TTM)20.4943.39
P/E percentile, own 5-yr range25th65th
P/B1.9716.79
Dividend yield2.60%0.85%
Profitability & growth
EPS (TTM)2.704.91
Net profit (TTM)$250.35M$1.95B
Revenue (TTM)$1.35B$11.56B
Provider revenue period date2026-06-252026-08-30
Revenue growth (YoY)-3.3%+10.9%
Gross margin87.6%51.0%
Operating margin19.3%23.6%
Net margin16.7%17.8%
Free cash flow (TTM)$344.51M$2.03B
Provider cash-flow period date2026-06-252026-08-30
Ownership & sentiment
Institutional ownership106.9%69.3%
Insider activity (12mo)15 buy / 35 sell41 buy / 9 sell
Short interest (% of float)6.4%2.6%
Analyst consensus100% buy (3)64% buy / 29% hold / 7% sell (14)
Analyst price target$88 (+58%)$225 (+2%)
StockVane view
StockVane Quant RatingD (26)C (66)
Company
Employees2,05148,100
Founded20041968

▲ marks the more favourable stock(s) on measures with a clear direction (lower P/E, higher yield, higher Quant Rating, better 1-year return). Analyst consensus counts each covering institution once, at its most recent rating. Not a recommendation. Quant Rating method: Data & Methodology.